Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Trialtrove
21 Nov 2019
A clear view of the past is often the surest way to plan for the future. The annual analysis of Phase I-III clinical trials from Citeline’s Trialtrove reveals the priorities and strategies of the biopharma industry. This infographic lets you clearly see the players, trials, and trends.
Topic Drug Development Landscape BioPharmaceutical Business Strategies
HBW Insight
By Tom Gallen 20 Nov 2019
Aspirational OTC products such as probiotics are outstripping demand for traditional symptom relievers, IQVIA's Andy Tisman told the recent Ceuta International Conference. Consumer health players must adapt their portfolios to cater for the more health conscious, informed, and digitally-connected consumer, Tisman advises.
Topic Business strategies
In Vivo
By Niharika Dandamudi 20 Nov 2019
The World Health Organization defines mobile health (mHealth) as a “medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants, and other wireless devices.”
Pink Sheet
By Francesca Bruce 20 Nov 2019
The Cancer Drugs Fund has improved access to oncology drugs, but if it is to remain fit for purpose it will need to evolve.
Topic Cancer
Generics Bulletin
By Aidan Fry 20 Nov 2019
In a bid to make better use of Amneal’s US portfolio and pipeline, the company is looking for international licensing partners, especially in Eastern Europe and China, as its new management team looks to restore growth and revive profit margins.
Topic Business strategies
Generics Bulletin
By Aidan Fry 20 Nov 2019
Accord Healthcare has secured commercial rights to Adienne’s novel lyophilized formulation of thiotepa in Europe, extending its portfolio of cancer treatments.
Topic Business strategies Cancer
Medtech Insight
By Elizabeth Orr 20 Nov 2019
A newly approved contact lens from CooperVision promises to slow the progression of nearsightedness when prescribed to children aged 8 to 12.
Topic FDA
Medtech Insight
By Marion Webb 20 Nov 2019
Sweden's Recipharm has agreed to buy UK-based Consort Medical for £505m ($652m) to become a leading inhalation-device company and top five global CDMO.
Topic Deal trends
Scrip
By Brian Yang 20 Nov 2019
The first country ever to approve a gene therapy, China has been lagging in the area since due to a lack of clear regulatory pathways and insufficient financial incentives. Now a new crop of developers are aiming to revitalize ambitions and make the country a major power for promising novel treatments for rare neurodegenerative conditions, retinal dystrophy, HIV and cancer.
Topic Policy and regulation
Scrip
By Kevin Grogan 20 Nov 2019
The former GlaxoSmithKline CEO has given his views on the prospects for healthcare systems, saying that intelligently applying digital technologies can lead to simpler, more cost-effective health systems.
Topic Digital Health
Pink Sheet
20 Nov 2019
Novartis finds itself facing possible criminal or civil action for admitted data manipulation on its application for Zolgensma, a gene therapy used to treat children with spinal muscular atrophy (SMA) – manipulation disclosed only after FDA approval. Pink Sheet was the first to report on the drug’s loss of EU accelerated assessment, nearly 3 weeks before the pharma giant admitted to submitting falsified data to FDA. Follow the scandal and anticipate its implications on the industry with Pink Sheet’s coverage and timeline.
Topic Cell and gene therapy FDA
Citeline Engage
By Pharma Intelligence 15 Nov 2019
Case Study: A Top 5 CRO partners with Informa Pharma Intelligence to mitigate risk, identify and recruit untapped investigators, and accelerate timelines
HBW Insight
By Eileen Francis 13 Nov 2019
In latest study casting doubt on the nutrients' effect on chronic illness, researchers find vitamin D and fish oil ineffective in staving off type 2 diabetics' kidney failure. Editorial also published in JAMA says further research is needed to analyze the nutrients’ possible benefits to diabetics with chronic kidney disease.
Topic Clinical trials
Pink Sheet
By Sue Sutter 13 Nov 2019
REDUCE-IT enrolled a higher risk group than the broad population targeted by Amarin’s proposed indication statement, agency says; although reviewers conclude an interaction between the mineral oil placebo and statins cannot be excluded, any impact would have been small and unlikely to change overall treatment effect.
Topic Drug review FDA
HBW Insight
By David Ridley 13 Nov 2019
Following a landmark win against the German government for the Rx-to-OTC switch of desloratadine last month, Novartis has again secured a victory in the German Higher Court system, this time to continue marketing its Biosan probiotics range in the country.
Pink Sheet
20 Nov 2019
Pink Sheet
20 Nov 2019
Pink Sheet
20 Nov 2019
Scrip
20 Nov 2019
Pink Sheet
20 Nov 2019
Pink Sheet
20 Nov 2019
Pink Sheet
20 Nov 2019
Scrip
20 Nov 2019
Medtech Insight
20 Nov 2019
Medtech Insight
20 Nov 2019
Pink Sheet
19 Nov 2019
Scrip
19 Nov 2019
Scrip
19 Nov 2019
Scrip
19 Nov 2019
Scrip
19 Nov 2019
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
04 Dec 2019
UK
Awards
12 Dec 2019 , 13:00
Webinar
11 Jan 2020 , 12:00
USA
Conference
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Keep up to date